Gary Speier, MS, JD, MBA is a registered U.S. patent attorney and a partner at Carlson Caspers with over 25 years experience in pharmaceutical patent law. He provides counsel on a broad range of patent-related matters and regularly conducts pre-suit investigations, intellectual property valuations and IP due diligence. Gary provides freedom-to-operate clearance reviews and opinions relating to infringement and validity, and develops patent procurement and patent prosecution strategies for domestic, international, and foreign jurisdictions. He has been involved in numerous post-grant proceedings (e.g., ex parte reexaminations and inter partes reviews) in front of the U.S. Patent and Trademark Office (USPTO). Gary has a strong technical and scientific background, as well as extensive, firsthand experience in USPTO practice and procedure. For the past several years, Gary has devoted significant time to preparing opinions relating to pharmaceutical patents, and has prepared and served numerous Hatch Waxman “Paragraph IV” notice letters and detailed statements. He also has represented generic pharmaceutical companies in ANDA patent litigations. Gary holds a JD from Temple University School of Law, an MBA from the University of Massachusetts, Amherst, M.Sc. Chemistry from Villanova University, B.Sc. Chemistry from Fordham University. He is admitted to the Supreme Courts of MN, NJ, ND and PA, the U.S. District Court for the District of NJ, U.S. Court of Appeals for the Federal Circuit and the U.S. Patent and Trademark Office.